Results 41 to 50 of about 35,468 (143)
Background HPV infection is the primary cause of cervical cancer, a leading cause of cancer among women in Kenya and many sub-Saharan African countries. High coverage of HPV vaccination is a World Health Organization priority to eliminate cervical cancer
Ruanne V. Barnabas +17 more
doaj +1 more source
Objective:To probe into the status quo of knowledge of human papillomavirus(HPV) and knowledgeattitudebeliefpractice(KAP) of HPV vaccine among undergraduate nursing students and analyze its influencing factors.Methods:A total of 365 undergraduate nursing
胡倩 +5 more
doaj
When public figures imperil the safety of the public with inaccurate claims that discourage vaccination, it is imperative that both organized medicine and individual physicians speak up.
Karlie A, Intlekofer +2 more
openaire +2 more sources
Background: With a growing vaccine-hesitant population and with the increase in oral cancers, particularly in a younger population, there is a heightened need for dental and medical providers to advocate for vaccination, including the human ...
Ana Karina Mascarenhas, BDS, MPH, DrPH +3 more
doaj +1 more source
Purpose: The purpose of this study was to examine knowledge, attitudes, barriers, and facilitators for human papillomavirus (HPV) vaccination among Latina mothers of HPV vaccine-eligible children in low-income urban areas, as well as useful strategies to
Rula Btoush +4 more
doaj +1 more source
Objective: The National Human Papillomavirus (HPV) Roundtable urges dental professionals to recommend HPV vaccination for eligible patients. Therefore, this study examined 1) how commonly dental hygienists recommended the HPV vaccine to age-eligible ...
Vinodh Bhoopathi +4 more
doaj +1 more source
Background In Canada, two vaccines that have demonstrated high efficacy against infection with human papillomavirus (HPV) types −16 and −18 are available.
Kohli Michele +4 more
doaj +1 more source
Abstract Human papilloma viruses (HPVs) are a group of viruses that can infect the stratified epithelium of the skin and mucosa. Based on their oncogenic potential, they can be divided into high risk and low risk types. HPV accounts for 7,30,000 cases of cancers all over the world. In June 2006, the first HPV vaccine – Gardasil – was approved
Aparajita Ghosh +3 more
openaire +3 more sources
Background: Vaccine hesitancy, delaying or refusing to vaccinate despite the availability of vaccines, impedes the progress of achieving optimal HPV vaccine coverage. Little is known about the sources of human papillomavirus (HPV) vaccine hesitancy among
Julie H. T. Dang +5 more
doaj +1 more source
HPV vaccination bridges to HPV screening [PDF]
Harper, Diane M, Sheinfeld Gorin, Sherri
openaire +2 more sources

